Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy-Reference-Cited by-同舟云学术

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Published:2014-06 Issue: Volume:183 Page:18-26
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kaminskas Lisa M.,McLeod Victoria M.,Ryan Gemma M.,Kelly Brian D.,Haynes John M.,Williamson Mark,Thienthong Neeranat,Owen David J.,Porter Christopher J.H.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Global Cancer Stat;Jemal,2011

2. Inhaled chemotherapy in lung cancer: future concept of nanomedicine;Zarogoulidis;Int. J. Nanomedicine,2012

3. Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells;Kang;BMC Cancer,2011

4. Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP);Murdter;Pneumologie,2000

5. Non-invasive imaging of barriers to drug delivery in tumors;Hassid;Microvasc. Res.,2008

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrimers for drug delivery: An overview of its classes, synthesis, and applications;Journal of Drug Delivery Science and Technology;2024-09

2. Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-08-01

3. Inhalable nanomedicine for lung cancer treatment;Smart Materials in Medicine;2024-06

4. Targeted Treatment of Lung Cancer using Nanomaterials: Prospective and Advances;Current Cancer Therapy Reviews;2024-05

5. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24